AbCellera Biologics Aktie

3,52 EUR +0,20 EUR +6,02 %

22:43:01

BMN

4,13 USD ±0,00 USD ±0,00 %

nachbörslich22:29:22

BTT

AbCellera Biologics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.878,74 Mio. EUR

Div. Rendite0,00%

WKNA2QKXS

ISINCA00288U1066

SymbolABCL

AbCellera Biologics Aktien News

Sortieren:Datum Meistgelesen

13.01.25BusinesswireAbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

21.11.24BusinesswireAbCellera to Present at Upcoming Investor Conferences in December and January

04.11.24BusinesswireAbCellera Reports Q3 2024 Business Results

WerbungAbCellera Biologics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

22.10.24BusinesswireAbCellera to Present at Upcoming Investor Conferences in November 2024

04.10.24BusinesswireAbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

26.09.24BusinesswireAbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

29.08.24BusinesswireAbCellera to Present at Upcoming Investor Conferences in September

06.08.24BusinesswireAbCellera Reports Q2 2024 Business Results

31.07.24BusinesswireAbCellera and Lilly Expand Collaboration to Develop Antibody Medicines

25.06.24BusinesswireAbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024

28.05.24BusinesswireAbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024

07.05.24BusinesswireAbCellera Reports Q1 2024 Business Results

01.05.24BusinesswireAbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies

08.04.24BusinesswireAbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024

03.04.24BusinesswireAbCellera to Report First Quarter 2024 Financial Results on May 7, 2024

16.11.23BusinesswireAbCellera to Present at the Piper Sandler 35th Annual Healthcare Conference on November 30, 2023

03.11.23BusinesswireAbCellera Presents New Data on Two T-Cell Engager Programs at SITC 2023

02.11.23BusinesswireAbCellera Reports Q3 2023 Business Results

01.11.23BusinesswirePrelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology

31.10.23BusinesswireAbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023

11.10.23BusinesswireAbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023

27.09.23BusinesswireAbCellera Announces Two T-Cell Engager Presentations at SITC 2023

20.09.23BusinesswireAbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron

13.09.23BusinesswireAbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology

24.07.23BusinesswireAbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing

06.07.23BusinesswireAbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023

29.05.23BusinesswireAbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023

24.05.23BusinesswireAbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients

04.05.23BusinesswireAbCellera Reports Q1 2023 Business Results

17.04.23BusinesswireAbCellera Presents New Data on T-Cell Engager Platform at AACR 2023

11.04.23BusinesswireAbCellera to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference on April 25, 2023

06.04.23BusinesswireAbCellera to Report First Quarter 2023 Financial Results on May 4, 2023

22.03.23BusinesswireAbCellera and RQ Bio Partner to Accelerate the Advancement of New Therapies for Infectious Disease

14.03.23BusinesswireAbCellera Announces Two Presentations on T-Cell Engager Discovery at AACR 2023

23.02.23BusinesswireAbCellera to Present at the Cowen 43rd Annual Health Care Conference on March 6, 2023

21.02.23BusinesswireAbCellera Reports Full Year 2022 Business Results

01.02.23BusinesswireAbCellera to Present at the SVB Securities Global Biopharma Conference on February 15, 2023

24.01.23BusinesswireAbCellera to Report Full Year 2022 Financial Results on February 21, 2023

20.01.23BusinesswireAbCellera Announces that the U.S. Patent Trial and Appeal Board Upholds Microfluidic Cell Culture Patent

AbCellera Biologics News

AbCellera Biologics News: auf dieser Seite finden Sie alle AbCellera Biologics News und Nachrichten zur AbCellera Biologics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch AbCellera Biologics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um AbCellera Biologics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.